George J. Morrow, Director of Neurocrine Biosciences NBIX, has filed 0 purchases and 3 sales on the open market. Over the past 12 months that comes to a net sale of $2.2M. The latest trade was on 05/27.

GM

GM

George J. Morrow

Director

Company

Neurocrine Biosciences NBIX

First filing

23/05/19

Trades

31 trades

Buys / sales

0 / 3

12-month net buying

−$2.2M

Last trade

05/27

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Neurocrine BiosciencesNBIX	Open-market sale10b5-1 plan	25/11/25	25/11/26	15,000 sh	$143.37	$2,150,550	−68.0%
Neurocrine BiosciencesNBIX	Open-market sale10b5-1 plan	24/03/14	24/03/15	40,000 sh2 trades	$139.42avg.	$5,576,600	−100.0%